Charles Giglio

Director, Global Project Management at Immunomic Therapeutics, Inc. - Rockville, MD, US

Charles Giglio's Contact Details
HQ
301-968-3501
Location
Baltimore,Maryland,21240,United States
Company
Immunomic Therapeutics, Inc.
Charles Giglio's Company Details
Immunomic Therapeutics, Inc. logo, Immunomic Therapeutics, Inc. contact details

Immunomic Therapeutics, Inc.

Rockville, MD, US • 50 - 99 Employees
BioTech/Drugs

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

DNA Vaccines LAMP Technology Allergy Oncology Animal Health Infectious Diseases B2B Biotech SaaS Commercial Physical Research Biotechnology
Details about Immunomic Therapeutics, Inc.
Frequently Asked Questions about Charles Giglio
Charles Giglio currently works for Immunomic Therapeutics, Inc..
Charles Giglio's role at Immunomic Therapeutics, Inc. is Director, Global Project Management.
Charles Giglio's email address is ***@immunomix.com. To view Charles Giglio's full email address, please signup to ConnectPlex.
Charles Giglio works in the Research industry.
Charles Giglio's colleagues at Immunomic Therapeutics, Inc. are Brent Bingham, Wei Shen, Melissa Kemp, Yoshimi Johnson, Timothy Coleman, Eric Winzer, Thomas Murphy and others.
Charles Giglio's phone number is 301-968-3501
See more information about Charles Giglio